MENU
HALO
AS OF
Nov 13, 04:59 PM (EDT)
Price
$71.19
Change
+$0.56 (+0.79%)
Capitalization
8.37B
102 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
HALO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Halozyme Therapeutics (HALO) Earnings Date & Reports

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

HALO is expected to report earnings to rise 8.72% to $1.87 per share on February 24

Halozyme Therapeutics HALO Stock Earnings Reports
Q4'25
Est.
$1.87
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.30
Q1'25
Beat
by $0.13
Q4'24
Beat
by $0.11
The last earnings report on November 03 showed earnings per share of $1.72, beating the estimate of $1.61. With 3.51M shares outstanding, the current market capitalization sits at 8.37B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
HALO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HALO showed earnings on November 03, 2025. You can read more about the earnings report here.
View AI-Driven Trading for HALO
A.I. Advisor
published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com